At the Chubb Limited Annual General Meeting of Shareholders held on May 19, 2022, the Company's shareholders approved an amendment to Article 6 of the Articles of Association to authorize the Company's Board of Directors to increase the Company's share capital within two years following the 2022 annual general meeting to a maximum amount equal to CHF.
/PRNewswire/ Nereid Therapeutics, a company discovering new disease treatments by applying pioneering research and technologies in biomolecular condensates,.